ESSA Pharma Inc.·4

Jan 5, 3:07 PM ET

Wood David S. 4

4 · ESSA Pharma Inc. · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2022-12-30
Wood David S.
Chief Financial Officer
Transactions
  • Purchase

    Common Shares

    2022-12-30$2.60/sh+8,302$21,58533,343 total
Footnotes (1)
  • [F1]The amount reflects the acquisition of shares pursuant to the ESSA Pharma Inc. Employee Stock Purchase Plan.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION